Sara Barmettler
Overview
Explore the profile of Sara Barmettler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
544
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Yin J, Hayes K, Ong M, Mizgerd J, Cunningham-Rundles C, Dominguez I, et al.
J Allergy Clin Immunol Pract
. 2024 Dec;
13(3):639-646.
PMID: 39672378
Background: NFKB1 encodes p105, which is processed to p50 to mediate canonical nuclear factor-κB (NF-κB) signaling. Although NF-κB is a central driver of inflammation and heterozygous NFKB1 variants are considered...
3.
Roberts J, Barmettler S, Murray J, Melvin J, Ye C
Immunotherapy
. 2024 Dec;
16(20-22):1247-1254.
PMID: 39648646
Background: Immune checkpoint inhibitors (ICIs) are first-line treatment for melanoma. The incidence of musculoskeletal immune-related adverse events (MSK irAEs) remains unclear. Objective: To estimate the relative risk of MSK irAEs...
4.
Allard-Chamard H, Hillier K, Ramseier M, Bertocchi A, Kaneko N, Premo K, et al.
Blood Adv
. 2024 Dec;
9(3):520-532.
PMID: 39626280
Patients with cytotoxic T-lymphocyte-associated protein 4 (CTLA4) deficiency exhibit profound humoral immune dysfunction, yet the basis for the B-cell defect is not known. We observed a marked reduction in transitional-to-follicular...
5.
6.
Sutherland N, Zhou B, Zhang L, Ong M, Hong J, Pak A, et al.
J Allergy Clin Immunol
. 2024 Nov;
155(2):605-615.
PMID: 39505278
Background: CD19-targeted chimeric antigen receptor T-cell therapy (CAR-T therapy) has revolutionized the treatment of hematologic malignancies. As these cells target CD19 receptors on B cells, there is the potential for...
7.
Forsyth K, Toothacre N, Jiwrajka N, Driscoll A, Shallberg L, Cunningham-Rundles C, et al.
Sci Immunol
. 2024 Oct;
9(100):eado0398.
PMID: 39365876
X chromosome inactivation (XCI) balances X-linked gene dosage between sexes. Unstimulated T cells lack cytological enrichment of X-inactive specific transcript (Xist) RNA and heterochromatic modifications on the inactive X chromosome...
8.
DiGiacomo D, Barmettler S
Curr Opin Pediatr
. 2024 Sep;
36(6):659-667.
PMID: 39254658
Purpose Of Review: Secondary hypogammaglobulinemia, or low serum immunoglobulins, is associated with a variety of medications or medical conditions and may be symptomatic and lead to increased infectious risk. There...
9.
Sacco K, Barmettler S
J Allergy Clin Immunol Pract
. 2024 Sep;
12(9):2547-2548.
PMID: 39244340
No abstract available.
10.
Elmoursi A, Zhou B, Ong M, Hong J, Pak A, Tandon M, et al.
J Clin Immunol
. 2024 Aug;
44(8):173.
PMID: 39110257
Health-related quality of life (HRQoL) measures individual well-being across physical, psychological, and social domains. Patients with predominantly antibody deficiency (PAD) are at risk for morbidity and mortality, however, the effect...